Skip to main content
Sign In
 

Program Meeting Schedule


Presented by the Division of Pulmonary Sciences and Critical Care Medicine

and the Aspen Lung Conference

Sponsored by the University of Colorado School of Medicine

Office of Continuing Medical Education

2017Aspen-1.jpg
2017Aspen-2.jpg

2017Aspen-3.jpg

2017Aspen-4.jpg

2017Aspen-5.jpg
2017Aspen-6.jpg
2017Aspen-7.jpg

2017Aspen-8.jpg

2017Aspen-9.jpg
2017Aspen-10.jpg
2017Aspen-11.jpg
2017Aspen-12.jpg







Presented by the Division of Pulmonary Sciences and Critical Care Medicine

and the Aspen Lung Conference

Sponsored by the University of Colorado School of Medicine

Office of Continuing Medical Education

Program Learning Objectives

 
The overarching objectives of the 2017 Thomas L. Petty Aspen Lung Conference are to:

1)  To provide an international forum for leading clinicians and researchers to exchange ideas regarding fundamental concepts underlying exposure induced lung diseases, including exposure assessment, molecular mechanisms of exposure, as well as susceptibility to exposure due to epigenetic, genetic and genomics mechanisms.
2) To stimulate and facilitate interactions and integration between the often siloed scientific fields of exposure biology, molecular biology, epigenetics, genetics, genomics and public health with the goal of identifying emerging, shared interests in exposure induced chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), asthma, cancer and diffuse lung diseases, at risk populations, and mechanisms to reduce or treat these diseases.
3)  To improve the efficiency and success of translating scientific advances into direct patient benefit globally and develop strategies to better implement scientific advances to reduce exposures and enhance lung health.
4)  To challenge and thereby stimulate the scientific interests of trainees, attracting a new generation of junior investigators into the field of exposure-induced lung disease and global health.
At the conclusion of this conference attendees will be able to:
1)  Discuss state-of-the-art concepts regarding the contribution of exposure and host susceptibility to chronic lung disease, including common diseases such as COPD, asthma, interstitial lung diseases, pulmonary fibrosis, and cancer.
2)  Appreciate the complex interactions between exposure, molecular mechanisms of exposure, as well as epigenetic, genetic and genomics mechanisms in the pathology of exposure-induced lung disease.
3)  Incorporate concepts from the growing fields of exposure biology and exposure assessment, stem cell biology, Omics, including epigenetics and transcriptomic, into experimental approaches to better define the mechanisms of exposure induced lung pathobiology.
4)  To develop novel strategies to reduce exposures and enhance lung health and prevent disease.

Intended Audience:  Local/Regional/National/International Environmental and Occupational health physicians/clinical/research (adult and pediatric)/, Research Physician-Scientists-Pulmonary Sciences, Critical Care and Sleep Medicine Physicians/Primary Care Physicians/General Medicine Physicians/Public Health RNs, NP, Research Coordinators

 

AMERICANS WITH DISABILITY ACT STATEMENT:

Please indicate if you have any need for auxiliary aides or special assistance services.
Accreditation Statement

The University of Colorado School of Medicine is accredited by the Accreditation Council for     Continuing Medical Education to provide continuing medical education for physicians. 

The University of Colorado School of Medicine designates this live activity for a maximum of 13 AMA PRA Category 1 Credits™.   Physicians should claim only the credit commensurate with the extent of their participation in the activity.